Opinion
Video
Author(s):
Early intervention in Spinal Muscular Atrophy is crucial for better outcomes, emphasizing the need for timely treatment to prevent irreversible disability.
Clinical Brief: Treatment Timing for Patients With SMA Across Age Groups
Main Discussion Topics
Key Points for Physicians
Notable Insights
Assessment tools developed for specific age groups or functional levels may have floor/ceiling effects that limit their utility in other populations, necessitating alternative evaluation methods to document meaningful changes.
Clinical Significance
While treatment timing is critical across all SMA age groups, physicians must adapt intervention timelines and outcome measurements to appropriately assess and document treatment benefits in older patients.